Creo Medical Wins Prestigious King’s Innovation Award
Company Announcements

Creo Medical Wins Prestigious King’s Innovation Award

Creo Medical (GB:CREO) has released an update.

Creo Medical Group plc, a leader in minimally invasive surgical endoscopy, has been honored with the prestigious King’s Award for Enterprise in Innovation. The company’s flagship technology, the Speedboat device, leverages its advanced CROMA platform to perform surgeries from within the body, offering significant patient benefits and cost savings. The recognition reflects Creo’s impact on healthcare innovation, with their devices already enhancing patient outcomes and efficiency in over 20 NHS hospitals.

For further insights into GB:CREO stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskCreo Medical Reports Share Capital and Voting Rights
TipRanks UK Auto-Generated NewsdeskCreo Medical CFO’s Strategic Share Transaction
TipRanks UK Auto-Generated NewsdeskCreo Medical CFO Engages in Strategic Share Transactions
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App